Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-05-05NCT04317534

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Greg Durm, MD1
Merck Sharp & Dohme LLC650

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Indiana University Melvin and Bren Simon Cancer CenterIndianapolisUnited States17
Moffit Cancer CenterTampaUnited States20
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
Penn State Cancer InstituteHersheyUnited States17
Providence Health & Services - OregonPortlandUnited States1
Rutgers Cancer Institute of New JerseyNew BrunswickUnited States223
Univeristy of WisconsinMadisonUnited States1
University of Illinois Cancer CenterChicagoUnited States34
University of Iowa Hospitals and ClinicsIowa CityUnited States99
University of MinnesotaMinneapolisUnited States325
University of Nebraska Medical CenterOmahaUnited States397
University of Virginia Health SystemCharlottesvilleUnited States57
Virginia Commonwealth UniversityRichmondUnited States156